It’s been a long time coming, but FIRSTsense Medical is getting ready to begin selling its new breast cancer screening platform.
The Pontiac-based firm’s breast cancer test uses robotics and software that emulates a manual test. FIRSTsense Medical claims that its technology achieves a 95-percent detection rate and has been validated in a 2,000-person trial.
“We hope to be in the market in June,” says Paul Angott, president and founder of FIRSTsense Medical.
The 5-year-old firm has hired four people (software and mechanical engineers) over the last year to help get the technology to this point. The team of a dozen people helped FIRSTsense Medical make the semifinals of last month’s Accelerate Michigan Innovation Competition.
FIRSTsense Medical has raised $5 million in seed capital and is in the midst of raising another $5 million in a Series B round. It is also working with a contract sales company to make sales directly to hospitals and medical centers.
Source: Paul Angott, president & founder of FIRSTsense Medical
Writer: Jon Zemke
Read more about Metro Detroit’s growing entrepreneurial ecosystem at SEMichiganStartup.com.